Nucleoside Analog 2′,3′-Isopropylidene-5-Iodouridine as Novel Efficient Inhibitor of HIV-1

Nucleoside reverse transcriptase inhibitors are the first class of drugs to be approved by the FDA for the suppression of HIV-1 and are widely used for this purpose in combination with drugs of other classes. Despite the progress in HIV-1 treatment, there is still the need to develop novel efficient...

Descripción completa

Detalles Bibliográficos
Autores principales: Glumakova, Ksenia, Ivanov, Georgy, Vedernikova, Valeria, Shyrokova, Lena, Lebedev, Timofey, Stomakhin, Andrei, Zenchenko, Anastasia, Oslovsky, Vladimir, Drenichev, Mikhail, Prassolov, Vladimir, Spirin, Pavel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10610023/
https://www.ncbi.nlm.nih.gov/pubmed/37896149
http://dx.doi.org/10.3390/pharmaceutics15102389

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10610023/
https://www.ncbi.nlm.nih.gov/pubmed/37896149
http://dx.doi.org/10.3390/pharmaceutics15102389

Ejemplares similares